Objective This article aims to present updated therapeutic options for fetal congenital
heart diseases. Methods Data source for the present study was based on comprehensive literature retrieval
on fetal cardiac interventions in terms of indications, technical approaches and
clinical outcomes. Results About 5% of fetal congenital heart diseases are critical and timely intrauterine
intervention may alleviate heart function. Candidates for fetal cardiac
interventions are limited. These candidates may include critical aortic valve
stenosis with evolving hypoplastic left heart syndrome, pulmonary atresia with an
intact ventricular septum and evolving hypoplastic right heart syndrome, and
hypoplastic left heart syndrome with an intact or highly restrictive atrial septum
as well as fetal heart block. The advocated option are prenatal aortic
valvuloplasty, pulmonary valvuloplasty, creation of atrial communication and fetal
cardiac pacing. Conclusion Fetal cardiac interventions are feasible at midgestation with gradually improved
technical success and fetal/postnatal survival due mainly to a well-trained
multidisciplinary team, sophisticated equipment and better postnatal care.